Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Foster

Showing results (1411-1420 of 1,472) with videos related to

Pageof 148
Sort By:
Advanced Biology|March 28, 2022
Understanding Suboptimal Response to Immune Checkpoint InhibitorsMojun Zhu, Henan Zhang, Katrina S Pedersen, et al.
The New England Journal of Medicine|June 24, 2011
Telaprevir for retreatment of HCV infectionStefan Zeuzem, Pietro Andreone, Stanislas Pol, et al.
JCI Insight|February 7, 2023
Mineralocorticoid receptor antagonism in diabetes reduces albuminuria by preserving the glomerular endothelial glycocalyxMichael Crompton, Joanne K Ferguson, Raina D Ramnath, et al.
Journal of Hepatology|January 7, 2015
STARTVerso1: A randomized trial of faldaprevir plus pegylated interferon/ribavirin for chronic HCV genotype-1 infectionPeter Ferenci, Tarik Asselah, Graham R Foster, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 20, 2009
Functional and clinical significance of variants localized to 8q24 in colon cancerMine S Cicek, Susan L Slager, Sara J Achenbach, et al.
Gut|February 11, 2016
Defective monocyte oxidative burst predicts infection in alcoholic hepatitis and is associated with reduced expression of NADPH oxidaseNikhil Vergis, Wafa Khamri, Kylie Beale, et al.
Surgery|November 9, 2023
The effect of hormonal secretion on survival in adrenocortical carcinoma: A multi-center studyAlaa Sada, Trenton R Foster, Ruaa Al-Ward, et al.
Cardiovascular Diabetology|February 2, 2024
Heparanase inhibition as a systemic approach to protect the endothelial glycocalyx and prevent microvascular complications in diabetesMonica Gamez, Hesham E Elhegni, Sarah Fawaz, et al.
International Journal of Cancer|March 19, 2021
Outcomes on anti-VEGFR-2/paclitaxel treatment after progression on immune checkpoint inhibition in patients with metastatic gastroesophageal adenocarcinomaLionel A Kankeu Fonkoua, Sakti Chakrabarti, Mohamad B Sonbol, et al.
Cancer Prevention Research (Philadelphia, Pa.)|March 2, 2021
Randomized Phase II Trial of Polyphenon E versus Placebo in Patients at High Risk of Recurrent Colonic NeoplasiaFrank A Sinicrope, Thomas R Viggiano, Navtej S Buttar, et al.
Pageof 148

Showing results (1411-1420 of 1,472) with videos related to

Sort By:
Pageof 148
Advanced Biology|March 28, 2022
Understanding Suboptimal Response to Immune Checkpoint InhibitorsMojun Zhu, Henan Zhang, Katrina S Pedersen, et al.
The New England Journal of Medicine|June 24, 2011
Telaprevir for retreatment of HCV infectionStefan Zeuzem, Pietro Andreone, Stanislas Pol, et al.
JCI Insight|February 7, 2023
Mineralocorticoid receptor antagonism in diabetes reduces albuminuria by preserving the glomerular endothelial glycocalyxMichael Crompton, Joanne K Ferguson, Raina D Ramnath, et al.
Journal of Hepatology|January 7, 2015
STARTVerso1: A randomized trial of faldaprevir plus pegylated interferon/ribavirin for chronic HCV genotype-1 infectionPeter Ferenci, Tarik Asselah, Graham R Foster, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 20, 2009
Functional and clinical significance of variants localized to 8q24 in colon cancerMine S Cicek, Susan L Slager, Sara J Achenbach, et al.
Gut|February 11, 2016
Defective monocyte oxidative burst predicts infection in alcoholic hepatitis and is associated with reduced expression of NADPH oxidaseNikhil Vergis, Wafa Khamri, Kylie Beale, et al.
Surgery|November 9, 2023
The effect of hormonal secretion on survival in adrenocortical carcinoma: A multi-center studyAlaa Sada, Trenton R Foster, Ruaa Al-Ward, et al.
Cardiovascular Diabetology|February 2, 2024
Heparanase inhibition as a systemic approach to protect the endothelial glycocalyx and prevent microvascular complications in diabetesMonica Gamez, Hesham E Elhegni, Sarah Fawaz, et al.
International Journal of Cancer|March 19, 2021
Outcomes on anti-VEGFR-2/paclitaxel treatment after progression on immune checkpoint inhibition in patients with metastatic gastroesophageal adenocarcinomaLionel A Kankeu Fonkoua, Sakti Chakrabarti, Mohamad B Sonbol, et al.
Cancer Prevention Research (Philadelphia, Pa.)|March 2, 2021
Randomized Phase II Trial of Polyphenon E versus Placebo in Patients at High Risk of Recurrent Colonic NeoplasiaFrank A Sinicrope, Thomas R Viggiano, Navtej S Buttar, et al.
Pageof 148